HCID 67003855, compound → HCID 67002779, compound
Reaction equation
[Cl:1][C:2]1[C:3]([C:25]2[S:29][C:28]([C:30]3([O:34]COC)[CH2:33][CH2:32][CH2:31]3)=[N:27][CH:26]=2)=[C:4]2[CH:10]=[C:9]([C:11]3[CH:16]=[CH:15][C:14]([NH:17][C:18](=[O:23])[CH2:19][N:20]([CH3:22])[CH3:21])=[C:13]([F:24])[CH:12]=3)[NH:8][C:5]2=[N:6][CH:7]=1.ClC1C(C2SC(C3(OCOC)CCC3)=NC=2)=C2C=C(C3N=C(C4CCCN(C(OC(C)(C)C)=O)C4)ON=3)NC2=NC=1>>[Cl:1][C:2]1[C:3]([C:25]2[S:29][C:28]([C:30]3([OH:34])[CH2:31][CH2:32][CH2:33]3)=[N:27][CH:26]=2)=[C:4]2[CH:10]=[C:9]([C:11]3[CH:16]=[CH:15][C:14]([NH:17][C:18](=[O:23])[CH2:19][N:20]([CH3:22])[CH3:21])=[C:13]([F:24])[CH:12]=3)[NH:8][C:5]2=[N:6][CH:7]=1Participants
3
Procedure
The title compound was prepared as described in Example 22E, substituting N-(4-(5-chloro-4-(2-(1-(methoxymethoxy)cyclobutyl)thiazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl)-2-fluorophenyl)-2-(dimethylamino)acetamide (Example 64C) for 1 tert-butyl 3-(3-(5-chloro-4-(2-(1-(methoxymethoxy)cyclobutyl)thiazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl)-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate (Example 22D). 1H NMR (400 MHz, DMSO-d6) ppm 12.57 (s, 1H) 9.63 (s, 1H) 8.34 (s, 1H) 8.27 (s, 1H) 8.10 (t, 1H) 8.01 (dd, 1H) 7.85 (dd, 1H) 7.15 (s, 1H) 6.68 (s, 1H) 3.14 (s, 2H) 2.64 (m, 2H) 2.42 (m, 2H) 2.32 (s, 6H) 198 (m, 2H); MS ESI(+) m/z 500.1 [M+H]+.
Sources & evidence
- ORD record
- ord-e5d14bf756724b84b002e741192c14cd
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691810B2
Reaction notes
Loading…